Knockdown of lncRNA TUG1 Enhances Radiosensitivity of Prostate Cancer via the TUG1/miR-139-5p/SMC1A Axis

References

• Diamond AM. Selenoproteins of the human prostate: unusual properties and role in cancer etiology. Biol Trace Elem Res. 2019;192(1):51–59. doi:10.1007/s12011-019-01809-0.31300958
   PubMed Web of Science ®Google Scholar
• Xu T, Liu CL, Li T, et al. LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis. Eur Rev Med Pharmacol Sci. 2019;23(11):4698–4705. doi:10.26355/eurrev_201906_18062.31210308
   PubMed Web of Science ®Google Scholar
• Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618–629. doi:10.1016/j.eururo.2016.08.003.27568654
   PubMed Web of Science ®Google Scholar
• Yang P, Yang Y, An W, et al. The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway. J Gastroenterol Hepatol. 2017;32(4):837–845. doi:10.1111/jgh.13606.27696511
   PubMed Web of Science ®Google Scholar
• Wu D, Li Y, Zhang H, et al. Knockdown of lncRNA PVT1 enhances radiosensitivity in non-small cell lung cancer by sponging Mir-195. Cell Physiol Biochem. 2017;42(6):2453–2466. doi:10.1159/000480209.28848163
   PubMedGoogle Scholar
• Yang J, Hao T, Sun J, et al. Long noncoding RNA GAS5 modulates alpha-solanine-induced radiosensitivity by negatively regulating miR-18a in human prostate cancer cells. Biomed Pharmacother. 2019;112:108656. doi:10.1016/j.biopha.2019.108656.30970507
   PubMed Web of Science ®Google Scholar
• Yang B, Tang X, Wang Z, et al. TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a. Biosci Rep. 2018;38(5). doi:10.1042/BSR20180677.
   Google Scholar
• Guo BH, Zhao Q, Li HY. TUG1 promotes the development of prostate cancer by regulating RLIM. Eur Rev Med Pharmacol Sci. 2019;23(5):1926–1933. doi:10.26355/eurrev_201903_17230.30915735
   PubMed Web of Science ®Google Scholar
• Yang XL, Wei C, Zhang YB, et al. Long noncoding RNA TUG1 promotes progression via upregulating DGCR8 in prostate cancer. Eur Rev Med Pharmacol Sci. 2019;23(6):2391–2398. doi:10.26355/eurrev_201903_17385.30964164
   PubMed Web of Science ®Google Scholar
• Jiang H, Hu X, Zhang H, et al. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression. Radiat Oncol. 2017;12(1):65. doi:10.1186/s13014-017-0802-3.28376901
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang Y, Ding J, et al. miR-17-3p downregulates mitochondrial antioxidant enzymes and enhances the radiosensitivity of prostate cancer cells. Mol Ther Nucleic Acids. 2018;13:64–77. doi:10.1016/j.omtn.2018.08.009.30240971
   PubMedGoogle Scholar
• Li X, Chen W, Jin Y, et al. miR-142-5p enhances cisplatin- induced apoptosis in ovarian cancer cells by targeting multiple anti- apoptotic genes. Biochem Pharmacol. 2019;161:98– 112. doi:10.1016/j.bcp.2019.01.009.30639456
   PubMed Web of Science ®Google Scholar
• Yan J, Yang B, Lin S, et al. Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer. Gastric Cancer. 2019;22(2):302–313. doi:10.1007/s10120-018-0872-4.30178386
   PubMed Web of Science ®Google Scholar
• Mao A, Liu Y, Wang Y, et al. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells. Tumour Biol. 2016;37(4):4831–4840. doi:10.1007/s13277-015-4336-8.26520443
   PubMedGoogle Scholar
• Yang B, Zhang W, Sun D, et al. Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5. Biomed Pharmacother. 2019;109:2128–2135. doi:10.1016/j.biopha.2018.09.029.30551470
   PubMed Web of Science ®Google Scholar
• Sun Q, Weng D, Li K, et al. MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1. Oncol Lett. 2018;16(1):793–800. doi:10.3892/ol.2018.8773.29963147
   PubMed Web of Science ®Google Scholar
• Pajic M, Froio D, Daly S, et al. miR-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense. Cancer Res. 2018;78(2):501–515. doi:10.1158/0008-5472.CAN-16-3105.29180477
   PubMed Web of Science ®Google Scholar
• Zhao C, Wang S, Zhao Y, et al. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia. J Cell Physiol. 2019;234(5):6161–6172. doi:10.1002/jcp.27393.30246348
   PubMed Web of Science ®Google Scholar
• Pan XW, Gan SS, Ye JQ, et al. SMC1A promotes growth and migration of prostate cancer in vitro and in vivo. Int J Oncol. 2016;49(5):1963–1972. doi:10.3892/ijo.2016.3697.27667360
   PubMed Web of Science ®Google Scholar
• Yadav S, Kowolik CM, Lin M, et al. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties. Mol Carcinog. 2019;58(1):113–125. doi:10.1002/mc.22913.30242889
   PubMed Web of Science ®Google Scholar
• Hoey C, Ray J, Jeon J, et al. MiRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation. Mol Oncol. 2018;12(8):1324–1341. doi:10.1002/1878-0261.1232829845714
   PubMed Web of Science ®Google Scholar
• Liva KKJ, Schmitt Gen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262.11846609
   PubMed Web of Science ®Google Scholar
• Huang X, Taeb S, Jahangiri S, et al. MiRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res. 2013;73(23):6972–6986. doi:10.1158/0008-5472.CAN-13-1657.24145350
   PubMed Web of Science ®Google Scholar
• Gang Zhu KZ. Chinese prostate cancer screening: current situation and challenges. J Shandong Univ. 2019;57(1):11–15. doi:10.6040/j.issn.1671-7554.0.2018.1053.
   Google Scholar
• Liu AM, Zhu Y, Huang ZW, et al. Long noncoding RNA FAM201A involves in radioresistance of non-small-cell lung cancer by enhancing EGFR expression via miR-370. Eur Rev Med Pharmacol Sci. 2019;23(13):5802–5814. doi:10.26355/eurrev_201907_18319.31298332
   PubMed Web of Science ®Google Scholar
• Sun Z, Huang G, Cheng H. Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder. Cancer Manag Res. 2019;11:6079–6090. doi:10.2147/CMAR.S200998.31308746
   PubMed Web of Science ®Google Scholar
• El Bezawy R, Tinelli S, Tortoreto M, et al. MiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. J Exp Clin Cancer Res. 2019;38(1):51. doi:10.1186/s13046-019-1060-z.30717752
   PubMedGoogle Scholar
• El Bezawy R, Cominetti D, Fenderico NR, et al. MiR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis. Cancer Lett. 2017;395:53–62. doi:10.1016/j.canlet.2017.02.033.28274892
   PubMed Web of Science ®Google Scholar
• Sarogni P, Palumbo O, Servadio A, et al. Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development. J Exp Clin Cancer Res. 2019;38(1):108. doi:10.1186/s13046-019-1116-0.30823889
   PubMedGoogle Scholar
• Wang J, Yu S, Cui L, et al. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer. BMC Cancer. 2015;15:90. doi:10.1186/s12885-015-1085-4.25884313
   PubMed Web of Science ®Google Scholar
• Zhou P, Xiao N, Wang J, et al. SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis. Cancer Lett. 2017;385:39–45. doi:10.1016/j.canlet.2016.10.041.27826041
   PubMed Web of Science ®Google Scholar
• Li J, Feng W, Chen L, et al. Downregulation of SMC1A inhibits growth and increases apoptosis and chemosensitivity of colorectal cancer cells. J Int Med Res. 2016;44(1):67–74. doi:10.1177/0300060515600188.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Z, Wang R, et al. siRNA-mediated knockdown of SMC1A expression suppresses the proliferation of glioblastoma cells. Mol Cell Biochem. 2013;381(1–2):209–215. doi:10.1007/s11010-013-1704-9.23754617
   PubMed Web of Science ®Google Scholar
• Ma Z, Lin M, Li K, et al. Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells. Int J Clin Exp Pathol. 2013;6(5):862–869.23638217
   PubMed Web of Science ®Google Scholar